OBJECTIVE: In this paper a new checklist (CLCE-24) for identification of cognitive and emotional problems after stroke is presented. The CLCE-24 is intended to support a clinical interview by health care professionals other than the trained (neuro)psychologist. METHODS: Patients were interviewed with the CLCE-24, 6 months post stroke. Usability was determined by interviews. Quality of the self-report version was determined using reference instruments (MMSE, CAMCOG). RESULTS: Sixty-nine patients participated in the study (37 men; mean age 66 years). Both patients and assessors were positive about the use of the CLCE-24. Eighty percent of the patients had cognitive and/or emotional problems (73% cognitive; 51% emotional problems). Patients with complaints on the CLCE-24 also showed problems on the MMSE and the CAMCOG (p<0.05). The CLCE-24 was a predictor of the MMSE and CAMCOG (Adj. R(2)=0.13 and 0.16, respectively) at 12 months post stroke. Internal consistency of the CLCE-24 was good (alpha of 0.81). CONCLUSIONS: The CLCE-24 is a usable and valid instrument for cognitive screening by health care professionals in the stroke service in the chronic phase after stroke.
OBJECTIVE: In this paper a new checklist (CLCE-24) for identification of cognitive and emotional problems after stroke is presented. The CLCE-24 is intended to support a clinical interview by health care professionals other than the trained (neuro)psychologist. METHODS:Patients were interviewed with the CLCE-24, 6 months post stroke. Usability was determined by interviews. Quality of the self-report version was determined using reference instruments (MMSE, CAMCOG). RESULTS: Sixty-nine patients participated in the study (37 men; mean age 66 years). Both patients and assessors were positive about the use of the CLCE-24. Eighty percent of the patients had cognitive and/or emotional problems (73% cognitive; 51% emotional problems). Patients with complaints on the CLCE-24 also showed problems on the MMSE and the CAMCOG (p<0.05). The CLCE-24 was a predictor of the MMSE and CAMCOG (Adj. R(2)=0.13 and 0.16, respectively) at 12 months post stroke. Internal consistency of the CLCE-24 was good (alpha of 0.81). CONCLUSIONS: The CLCE-24 is a usable and valid instrument for cognitive screening by health care professionals in the stroke service in the chronic phase after stroke.
Authors: Jerry P Nolan; Claudio Sandroni; Bernd W Böttiger; Alain Cariou; Tobias Cronberg; Hans Friberg; Cornelia Genbrugge; Kirstie Haywood; Gisela Lilja; Véronique R M Moulaert; Nikolaos Nikolaou; Theresa Mariero Olasveengen; Markus B Skrifvars; Fabio Taccone; Jasmeet Soar Journal: Intensive Care Med Date: 2021-03-25 Impact factor: 17.440
Authors: Véronique Rmp Moulaert; Jeanine A Verbunt; Wilbert Gm Bakx; Anton Pm Gorgels; Marc Cftm de Krom; Peter Htg Heuts; Derick T Wade; Caroline M van Heugten Journal: Clin Rehabil Date: 2011-05-12 Impact factor: 3.477
Authors: Véronique R M Moulaert; Jolanda C M van Haastregt; Derick T Wade; Caroline M van Heugten; Jeanine A Verbunt Journal: BMC Health Serv Res Date: 2014-01-23 Impact factor: 2.655
Authors: Hugo P Aben; Yael D Reijmer; Johanna Ma Visser-Meily; Jacoba M Spikman; Jeroen de Bresser; Geert Jan Biessels; Paul Lm de Kort Journal: JMIR Res Protoc Date: 2018-05-28
Authors: Annemarie P M Stiekema; Christine Resch; Mireille Donkervoort; Natska Jansen; Kitty H M Jurrius; Judith M Zadoks; Caroline M van Heugten Journal: Trials Date: 2020-11-17 Impact factor: 2.279
Authors: J P L Slenders; R M Van den Berg-Vos; C M van Heugten; J M A Visser-Meily; S M A A Evers; R J de Haan; J M de Man-van Ginkel; V I H Kwa Journal: BMC Health Serv Res Date: 2020-11-17 Impact factor: 2.655